Literature DB >> 25178327

Serum and tumor microenvironment IL-8 values in different stages of colorectal cancer.

Maria Bălăşoiu1, Andrei Theodor Bălăşoiu, Stelian Ştefăniţă Mogoantă, Alexandru Bărbălan, Alex Emilian Stepan, Raluca Niculina Ciurea, Dragoş Ovidiu Alexandru, Aurelia Enescu, Laurenţiu Mogoantă.   

Abstract

INTRODUCTION: Colorectal cancer represents a major cause of mortality and morbidity and occupies the third place as cancer incidence and the fourth place as cancer mortality. Colorectal cancer causes 608 000 deaths per year, despite correct applied treatment (surgery and chemotherapy). Interleukin 8 (IL-8) is an important proinflammatory cytokine with an important role in leukocyte chemoattraction. IL-8 also represents an important tumorigenic and proangiogenic factor.
MATERIALS AND METHODS: We have studied 68 patients aged between 55 and 70 years, hospitalized in the IInd Surgery Clinic of the Emergency County Hospital of Craiova, Romania. According to TNM grading, the patients were in stages II, III and IV. From these patients, we have prelevated two types of samples: serum and tumor fragment.
RESULTS: IL-8 values were significantly increased, both in serum and tumor supernatant. The highest IL-8 values were found in tumor supernatant and in advanced stages; IL-8 increased values were correlated with tumor growth and TNM stage.
CONCLUSIONS: IL-8 has an important role in colorectal cancer growth and metastasis and represents an important therapeutic target in this type of cancer. IL-8 represents also a predictor for colorectal cancer prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25178327

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  5 in total

1.  Serum cytokine profile as a potential prognostic tool in colorectal cancer patients - one center study.

Authors:  Paulina Czajka-Francuz; Tomasz Francuz; Sylwia Cisoń-Jurek; Aleksander Czajka; Marcin Fajkis; Bożena Szymczak; Maciej Kozaczka; Krzysztof Piotr Malinowski; Wojciech Zasada; Jerzy Wojnar; Jerzy Chudek
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-21

Review 2.  An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.

Authors:  Amaresh Mishra; Kamrul Hassan Suman; Nisha Nair; Jaseela Majeed; Vishwas Tripathi
Journal:  Mol Biol Rep       Date:  2021-08-24       Impact factor: 2.316

3.  The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis.

Authors:  Ruiling Yan; Hanlin Shuai; Xin Luo; Xueqin Wang; Baozhang Guan
Journal:  Biosci Rep       Date:  2017-10-06       Impact factor: 3.840

Review 4.  The CXCL8-CXCR1/2 pathways in cancer.

Authors:  Qian Liu; Anping Li; Yijun Tian; Jennifer D Wu; Yu Liu; Tengfei Li; Yuan Chen; Xinwei Han; Kongming Wu
Journal:  Cytokine Growth Factor Rev       Date:  2016-08-25       Impact factor: 7.638

5.  BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer.

Authors:  Fabiana Conciatori; Chiara Bazzichetto; Carla Azzurra Amoreo; Isabella Sperduti; Sara Donzelli; Maria Grazia Diodoro; Simonetta Buglioni; Italia Falcone; Senji Shirasawa; Giovanni Blandino; Gianluigi Ferretti; Francesco Cognetti; Michele Milella; Ludovica Ciuffreda
Journal:  Commun Biol       Date:  2020-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.